Menu
Back to Journals » Cancer Management and Research » Volume 14
Original Research
Bevacizumab is an Efficient Therapeutic Approach with Low Side Effects in Patient-Derived Xenografts of Adenoid Cystic Carcinoma of the Lacrimal Gland
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,011 | Dovepress* | 6,701+ | 326 | 7,027 | |
| PubMed Central* | 310 | 116 | 426 | ||
| Totals | 7,011 | 442 | 7,453 | ||
| *Since 6 March 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar